$2.23T
Total marketcap
$76.38B
Total volume
BTC 56.18%     ETH 9.01%
Dominance
Natera

Natera NTRA Stock

$235.15   2.775346%
Add to favorites
Market Cap
$33.68B
LOW - HIGH [24H]
$224.44 - $237.00
VOLUME [24H]
$226.50K
P/E Ratio
0
Earnings per share
-$1.62
ISIN
US6323071042
Price   Prediction

Natera Price Chart

Sorry, that's all we've gotfor now...

Natera NTRA Financial and Trading Overview

Natera stock price 235.15 USD
Previous Close 231.41 USD
Open 231.52 USD
Bid 209.19 USD x 200
Ask 239.95 USD x 200
Day's Range 219.58 - 234.14 USD
52 Week Range 131.81 - 256.36 USD
Volume 1.58M USD
Avg. Volume 1.41M USD
Market Cap 32.77B USD
Beta (5Y Monthly) 1.544
PE Ratio (TTM) N/A
EPS (TTM) -1.62 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 260.05 USD

NTRA Valuation Measures

Enterprise Value 32.29B USD
Trailing P/E N/A
Forward P/E -1097.994
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 13.102213
Price/Book (mrq) 18.408562
Enterprise Value/Revenue 12.913
Enterprise Value/EBITDA -120.689

Trading Information

Natera Stock Price History

Beta (5Y Monthly) 1.544
52-Week Change 35.82%
S&P500 52-Week Change 24.48%
52 Week High 256.36 USD
52 Week Low 131.81 USD
50-Day Moving Average 207.88 USD
200-Day Moving Average 206.57 USD

NTRA Share Statistics

Avg. Volume (3 month) 1.41M USD
Avg. Daily Volume (10-Days) 1.26M USD
Shares Outstanding 143.22M
Float 138.91M
Short Ratio 2.06
% Held by Insiders 3.01%
% Held by Institutions 96.09%
Shares Short 3.61M
Short % of Float 2.59%
Short % of Shares Outstanding 2.52%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin -9.048%
Operating Margin (ttm) -12.39%
Gross Margin 65.06%
EBITDA Margin -10.69%

Management Effectiveness

Return on Assets (ttm) -9.11%
Return on Equity (ttm) -15.018%

Income Statement

Revenue (ttm) 2.5B USD
Revenue Per Share (ttm) 18.07 USD
Quarterly Revenue Growth (yoy) 38.80%
Gross Profit (ttm) 1.63B USD
EBITDA -267576992 USD
Net Income Avi to Common (ttm) -226315008 USD
Diluted EPS (ttm) -1.62
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 1.09B USD
Total Cash Per Share (mrq) 7.6 USD
Total Debt (mrq) 240.08M USD
Total Debt/Equity (mrq) 13.53 USD
Current Ratio (mrq) 2.959
Book Value Per Share (mrq) 12.429

Cash Flow Statement

Operating Cash Flow (ttm) 211.02M USD
Levered Free Cash Flow (ttm) 136.92M USD

Profile of Natera

Country United States
State TX
City Austin
Address 13011 McCallen Pass
ZIP 78753
Phone 650 980 9190
Website https://www.natera.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 6135

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Q&A For Natera Stock

What is a current NTRA stock price?

Natera NTRA stock price today per share is 235.15 USD.

How to purchase Natera stock?

You can buy NTRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Natera?

The stock symbol or ticker of Natera is NTRA.

Which industry does the Natera company belong to?

The Natera industry is Diagnostics & Research.

How many shares does Natera have in circulation?

The max supply of Natera shares is 143.22M.

What is Natera Price to Earnings Ratio (PE Ratio)?

Natera PE Ratio is now.

What was Natera earnings per share over the trailing 12 months (TTM)?

Natera EPS is -1.62 USD over the trailing 12 months.

Which sector does the Natera company belong to?

The Natera sector is Healthcare.

Natera NTRA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us US Tech Composite IXIC US 25775.82 USD
-1.49
4.19B USD 25513.26 USD 25882.57 USD 4.19B USD
us US Tech Global Select Market Com NQGS US 12635.82 USD
-1.55
12513.27 USD 12692.24 USD
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
us US Tech Health Care IXHC US 1187.28 USD
+0.97
1174.72 USD 1190.38 USD
us US Tech Composite Total Return XCMP US 31781.81 USD
-1.53
31469.2 USD 31924.72 USD
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 4131.98 USD
-2.14
4089.8 USD 4163.55 USD
Select currency